From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board.

Target Oncol · 2026 · PMC13427782 · PMID 42467374

Europe PMC DOI

hedged sentence

0.1220

closest p · 2.4× alpha

0.1220

boldest claim

The sentences

a nonsignificant trendp = 0.122not close (p > 0.1)

In this analysis, external profiling showed a nonsignificant trend towards lower implementation rates (OR 0.62, 95% CI 0.33–1.12, p = 0.122).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.